HPV is definitely involved in the origin and development of genitoanal cancer of both genders (cervical cancer, vulval cancer, vaginal cancer, anal cancer and penile cancer). HPV types from the betapapillomaviruses (betaPV) genus may play a role in cutaneous squamous cell carcinoma. Functional data support a potential role for betaPV as cocarcinogens with UV, but with mechanisms likely to differ fundamentally to those established in anogenital cancer. HPV-specific antiviral agents are not currently available, but therapeutic anti- HPV vaccines are in development and would be especially appropriate for those persons for whom we can predict a high risk of multiple squamous cell carcinoma. Cutaneous squamous cell carcinomas are an eminent clinical problem in the management of immunosuppressed organ transplant recipients.

The following program has been organized in cooperation with the EADV (European Academy of Dermatology and Venereology) HPV Task Force and SCOPE (Skin Care in Organ Transplant Patients)


Program Committee:
J.N. Bouwes Bavinck (The Netherlands), G. Gross (Germany), J. Hercogova (Czech Republic), H. Pfister (Germany), M. Skerlev (Croatia)

The following sessions are of special interest to dermato-venereologists:

Sunday, July 8

TRAINING COURSE

A training course on fundamentals on HPV infection and cancer runs from 8.30 to 17.30. This course deals with all fundamentals of HPV infection and related diseases. A 90-minute section of the course (16.00 – 17.30) will focus on the following sites: anus, head&neck, skin

16.00 - 17.30	MTC2 - HPV infection & associated diseases in non-cervical sites: facts and figures Chair: Stina Syrjänen (Finland)
	HPV genital infection and diseases in men		A. Giuliano	USA
	Anal neoplasia: burden, epidemiology and prevention		J. Palefsky	USA
	The HPV cause of head and neck cancers: epidemiology, burden and new developments		M. Gillison	USA
	HPV associated diseases in the skin – current knowledge and perspectives		H. Pfister	Germany
	Discussion

Monday, July 9

MAIN SCIENTIFIC SESSIONS

8.00 - 9.30	MSS1 - HPV associated diseases in non-genital human sites: new challenges Chair: M. Gillison – K. Syrjänen
	Keynote lecture: HPV-associated cancers – a growing problem?		M. Stanley	UK
	(...)
	The role of papillomavirus infection in skin cancer development		J.N. Bouwes-Bavinck	The Netherlands
	HPV, oesophagus & lung: what evidence?		K. Syrjänen	Finland
	The significance of HPV in the colon & rectum		L. Lorenzon	Italy
9.30 - 11.00	MSS2 - HPV vaccines – update and perspectives Chair: J. Paavonen – M. Stanley

14.00 - 17.00	SEM 2- Seminar: HPV in dermatovenereology Coordination : G. Gross, J. Hercegova, H. Pfister, M. Skerlev
	Part I
	1. External genitalia and HPV associated diseases
	Epidemiology and burden of genital warts		S. Garland	Australia
	Epidemiology and burden of VIN		J. Bornstein	Israel
	Management
	- Genital warts		G. Gross	Germany
	- VIN		M. Hampl	Germany
	Prevention		A. Giuliano	USA
	Part II
	Epidemiology of papillomavirus infections and skin cancer in organ transplant recipients		J.N. Bouwes-Bavinck	The Netherlands
	Skin cancer in immunosuppressed patients		J. Hercogova	Czech Republic
	Molecular mechanisms of keratinocyte transformation		M. Tommasino	France
	Skin cancer development in beta-HPV transgenic mice		H. Pfister	Germany
	HPV – skin deep and beyond		M. Skerlev	Croatia
	Discussion – round table

Tuesday, July 10

MAIN SCIENTIFIC SESSION

8.00 - 10.00	Hot topics on HPV infection and diseases – exchanging points of view with the experts & public health representatives Chair: E. Franco – J. Peto
	(...)

EUROGIN CONSENSUS SESSSION ("Roadmap")

14.00 - 15.00	MSS7 - EUROGIN 2012 Roadmap Chair: S. Franceschi – M. Gillison
	Consensus meeting on HPV related cancers

This consensus conference will be organized between EUROGIN and the other scientific societies to establish a consensu on the impact of HPV infections on clinical practice related to cancers in the various relevant sites


SCIENTIFIC SESSION ON HPV AND SKIN CANCER

18.00 - 19.15	SS7: Non-cervical HPV associated diseases – current knowledge Chair: J. Palefsky – C. Lacey
	HPV, skin & sex		M. Skerlev	Croatia
	Update on HPV-associated oral cancer in men		A. Chaturvedi	USA
	New approaches to the treatment of AIN		J. Palefsky	USA
	Penile HPV infection and disease in HIV-infected men		C. Lacey	UK
	Female HPV data		R. Crawford	France
	Economic burden of non-cervical human papillomavirus-related cancers in Western Europe: a scoping review		N. Largeron	France

Wednesday, July 11

8.30 - 12.00	Vulvar diseases course + accreditation Coordinator:– J. Bornstein The satellite course on vulvar disease has been designed for clinicians who currently treat or diagnose women with cervical and vaginal disease. The faculty will discuss current knowledge of vulvar benign and premalignant disease, from various aspects: pathophysiology, clinical features, histological appearance, and treatment. Common and difficult cases will be presented and discussed
	Introduction		J. Bornstein	Israel
	Benign HPV lesions: diagnosis and treatment		M. Hampl	Germany
	Vulvar pain, etiology and diagnosis		J. Bornstein	Israel
	VIN – diagnosis, terminology		M. Sideri	Italy
	VIN – prevention and treatment		E. Joura	Austria
	Vulvar carcinoma - current treatment		M. Roy	Canada
	Vulvar pain: surgical and non-surgical treatments		J. Bornstein	Israel
	Psycho-sexual aspects of vulvar disease		M. Steben	Canada
	Summary and close